ProCE Banner Activity

Targeting Antigens in AML: New Advances in Antibody–Drug Conjugates and Other Antibody-Based Therapies

Slideset Download
In this downloadable slideset, Farhad Ravandi, MD, reviews current and investigational uses of immunotherapy for patients with AML.

Released: May 31, 2019

Expiration: May 29, 2020

No longer available for credit.

Share

Faculty

Farhad Ravandi

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Agios Pharmaceuticals

Boston Biomedical

Celgene TEXT Only

Daiichi Sankyo, Inc.

Program Director Disclosure

Program Director

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas